Global: Fixed dose the way to go on TB

Patients are at risk of developing resistance to Tuberculosis medicine due to lack of access to quality treatment, according to a report presented at the 41st Union World Conference on Lung Health. TB patients should ideally receive a six months fixed dose combination regimen at the cost of around US$26 per patient but in some countries this is not the case according to 'Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis'.